These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9291993)

  • 1. Implications of new dry fibrin sealant technology for trauma surgery.
    Holcomb JB; Pusateri AE; Hess JR; Hetz SP; Harris RA; Tock BB; Drohan WN; MacPhee MJ
    Surg Clin North Am; 1997 Aug; 77(4):943-52. PubMed ID: 9291993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of local pro-coagulant haemostatic agents for intra-cavity control of haemorrhage after trauma.
    Navarro A; Brooks A
    Eur J Trauma Emerg Surg; 2015 Oct; 41(5):493-500. PubMed ID: 26037982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Novel Fibrin Sealant Patch in Hemorrhage Control After Vascular or Hepatic Injury.
    Baker JE; Goodman MD; Makley AT; Stevens-Topie SM; Veile RA; Mahoney EJ; Heyl JR; Cox DB; Pritts TA; Athota KP
    Mil Med; 2019 Mar; 184(3-4):e290-e296. PubMed ID: 30007358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine.
    Acheson EM; Kheirabadi BS; Deguzman R; Dick EJ; Holcomb JB
    J Trauma; 2005 Oct; 59(4):865-74; discussion 874-5. PubMed ID: 16374275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage.
    Ward KR; Tiba MH; Holbert WH; Blocher CR; Draucker GT; Proffitt EK; Bowlin GL; Ivatury RR; Diegelmann RF
    J Trauma; 2007 Aug; 63(2):276-83; discussion 283-4. PubMed ID: 17693824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic hemostatics in trauma: a review.
    Recinos G; Inaba K; Dubose J; Demetriades D; Rhee P
    Ulus Travma Acil Cerrahi Derg; 2008 Jul; 14(3):175-81. PubMed ID: 18781411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-pressure fibrin sealant foam: an effective hemostatic agent for treating severe parenchymal hemorrhage.
    Kheirabadi BS; Sieber J; Bukhari T; Rudnicka K; Murcin LA; Tuthill D
    J Surg Res; 2008 Jan; 144(1):145-50. PubMed ID: 17583744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model.
    Matonick JP; Hammond J
    J Invest Surg; 2014 Dec; 27(6):360-5. PubMed ID: 25361019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue glues and nonsuturing techniques.
    Pursifull NF; Morey AF
    Curr Opin Urol; 2007 Nov; 17(6):396-401. PubMed ID: 17921773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New hemostatic agents in the combat setting.
    Cox ED; Schreiber MA; McManus J; Wade CE; Holcomb JB
    Transfusion; 2009 Dec; 49 Suppl 5():248S-55S. PubMed ID: 19954487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential uses of absorbable fibrin adhesive bandage for genitourinary trauma.
    Anema JG; Morey AF; Harris R; MacPhee M; Cornum RL
    World J Surg; 2001 Dec; 25(12):1573-7. PubMed ID: 11775194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic effectiveness of Fibrin pad after partial nephrectomy in swine.
    Hutchinson RW; Broughton D; Barbolt TA; Poandl T; Muench T; Rockar R; Johnson M; Hart J
    J Surg Res; 2011 May; 167(2):e291-8. PubMed ID: 20451926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the hemostatic efficacy of a new human fibrin sealant: is an antifibrinolytic agent necessary?
    Kheirabadi BS; Pearson R; Tuthill D; Rudnicka K; Holcomb JB; Drohan W; MacPhee MJ
    J Trauma; 2002 Jun; 52(6):1107-15. PubMed ID: 12045638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of aprotinin-free fibrin sealant versus absorbable hemostat.
    Fischer CP; Wood CG; Shen J; Batiller J; Hart JC; Patel B; Albala DM
    Clin Appl Thromb Hemost; 2011; 17(6):572-7. PubMed ID: 21873356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin sealant in preclinical and clinical studies.
    Jackson MR; Alving BM
    Curr Opin Hematol; 1999 Nov; 6(6):415-9. PubMed ID: 10546796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrhage control in the battlefield: role of new hemostatic agents.
    Alam HB; Burris D; DaCorta JA; Rhee P
    Mil Med; 2005 Jan; 170(1):63-9. PubMed ID: 15724857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a new fibrin sealant with standard topical hemostatic agents.
    Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
    Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and systemic hemostatics as an adjunct to control bleeding in trauma.
    Georgiou C; Neofytou K; Demetriades D
    Am Surg; 2013 Feb; 79(2):180-7. PubMed ID: 23336658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin solutions to control hemorrhage in the trauma patient.
    Ochsner MG
    J Long Term Eff Med Implants; 1998; 8(2):161-73. PubMed ID: 10181374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilia and advanced fibrin sealant technologies.
    Tock B; Drohan W; Hess J; Pusateri A; Holcomb J; MacPhee M
    Haemophilia; 1998 Jul; 4(4):449-55. PubMed ID: 9873774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.